Literature DB >> 22690253

Cataract surgery in patients taking alpha-1 antagonists: know the risks, avoid the complications.

Daniel M Handzel1, Sebastian Briesen, Steffen Rausch, Tilman Kälble.   

Abstract

BACKGROUND: The growing use of alpha-1 receptor antagonists in the treatment of benign prostatic hyperplasia (BPH) has created a new problem in ophthalmic surgery, the so-called intraoperative floppy iris syndrome (IFIS). This consists of a billowing iris, insufficient pupillary dilation with progressive intraoperative miosis, and protrusion of iris tissue through the tunnel and side port incision that are made for access to the anterior chamber during surgery. IFIS presents particular difficulties in cataract surgery which is carried out through the pupil with manipulations in the immediate vicinity of the iris. The complications range from poor visibility of the operative field to iris damage with the surgical instruments and to rupture of the posterior capsule, with loss of lens material into the vitreous body.
METHODS: Selective literature review.
RESULTS: Alpha-blockers have a direct effect on the alpha-receptors of the iris but also induce ultrastructural changes in the iridial stroma, leading to IFIS. The most important factor in avoiding complications of IFIS seems to be the ophthalmic surgeon's knowledge that the patient is taking an alpha-1 receptor antagonist.
CONCLUSION: A thorough medical history and an optimized information flow among all physicians treating the patient-the urologist, the family physician, and the ophthalmic surgeon-are essential for safe cataract surgery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22690253      PMCID: PMC3371631          DOI: 10.3238/arztebl.2012.0379

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  51 in total

1.  [Guidelines of German urologists on therapy of benign prostate syndrome].

Authors:  R Berges; K Dreikorn; K Höfner; U Jonas; K U Laval; S Madersbacher; M C Michel; R Muschter; M Oelke; L Pientka; C Tschuschke; U Tunn; H Palmtag; M Goepel; K Schalhhäuser; B Göckeel-Beining; A Heidenreich; H Rübben; K Schalkerhäuser; W Thon; J Thüroff; W Weidner
Journal:  Urologe A       Date:  2003-03-22       Impact factor: 0.639

Review 2.  Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia.

Authors:  Claus G Roehrborn; Debra A Schwinn
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

Review 3.  Urodynamic effects of alpha-adrenoceptor blockers: a review of clinical trials.

Authors:  Barbara B M Kortmann; Diamandis L Floratos; Lambertus A L M Kiemeney; Hessel Wijkstra; Jean J M C H de la Rosette
Journal:  Urology       Date:  2003-07       Impact factor: 2.649

4.  Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned alpha 1-adrenergic receptor subtypes.

Authors:  C D Richardson; C F Donatucci; S O Page; K H Wilson; D A Schwinn
Journal:  Prostate       Date:  1997-09-15       Impact factor: 4.104

Review 5.  International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update.

Authors:  J P Hieble; D B Bylund; D E Clarke; D C Eikenburg; S Z Langer; R J Lefkowitz; K P Minneman; R R Ruffolo
Journal:  Pharmacol Rev       Date:  1995-06       Impact factor: 25.468

6.  Alpha-blocker therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5alpha-reductase inhibitor dutasteride.

Authors:  J Barkin; M Guimarães; G Jacobi; D Pushkar; S Taylor; O B van Vierssen Trip
Journal:  Eur Urol       Date:  2003-10       Impact factor: 20.096

7.  Intraoperative floppy iris syndrome associated with tamsulosin.

Authors:  David F Chang; John R Campbell
Journal:  J Cataract Refract Surg       Date:  2005-04       Impact factor: 3.351

8.  Pharmacologic pupil dilation as a predictive test for the risk for intraoperative floppy-iris syndrome.

Authors:  Alessandra Casuccio; Giovanni Cillino; Carlo Pavone; Emanuela Spitale; Salvatore Cillino
Journal:  J Cataract Refract Surg       Date:  2011-08       Impact factor: 3.351

9.  EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).

Authors:  Stephan Madersbacher; Gerasimos Alivizatos; Jorgen Nordling; Carlos Rioja Sanz; Mark Emberton; Jean J M C H de la Rosette
Journal:  Eur Urol       Date:  2004-11       Impact factor: 20.096

10.  The development of human benign prostatic hyperplasia with age.

Authors:  S J Berry; D S Coffey; P C Walsh; L L Ewing
Journal:  J Urol       Date:  1984-09       Impact factor: 7.450

View more
  4 in total

Review 1.  Intraoperative floppy iris syndrome: an updated review of literature.

Authors:  Amit Kumar; Amit Raj
Journal:  Int Ophthalmol       Date:  2021-06-29       Impact factor: 2.031

2.  [Managing complications in intraoperative floppy iris syndrome].

Authors:  D M Handzel; S Rausch; T Kälble; S Briesen
Journal:  Ophthalmologe       Date:  2013-04       Impact factor: 1.059

3.  Modified corneal incisions in intraoperative floppy iris syndrome (IFIS)-prone patients.

Authors:  Sharon Armarnik; Michael Mimouni; Eli Rosen; Ehud I Assia; Fani Segev
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-09       Impact factor: 3.117

Review 4.  Ten years of intraoperative floppy iris syndrome in the era of α-blockers.

Authors:  Andreas Lunacek; Badereddin Mohamad Al-Ali; Christian Radmayr; Maria Weber; Wolfgang Horninger; Oliver Findl; Eugen Plas
Journal:  Cent European J Urol       Date:  2017-12-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.